Login / Signup

Response to Surgery Assessments for Sparing Radioiodine Remnant Ablation in Intermediate-risk Papillary Thyroid Cancer.

Xin ZhangJie-Rui LiuZhuan-Zhuan MuXin-Qi ChengYan-Song Lin
Published in: The Journal of clinical endocrinology and metabolism (2022)
Through the three-tiered assessments with response to surgery highlighted, postoperative ER and IDR spared from RAI remnant ablation may indicate similar favorable responses in intermediate-risk PTC patients during 23.6 months follow-up.
Keyphrases